Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Tata memorial Centre Mumbai
Eligibility
Inclusion criteria
Inclusion criteria: All adult patients undergoing elective cancer surgery and requiring intraoperative inotrope or vasopressor drug infusions will be studied
Exclusion criteria
Exclusion criteria: Emergency surgeries
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of adult patients undergoing elective cancer surgery requiring intraoperative vasopressor / inotrope infusionsTimepoint: At completion of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To study the indication for starting vasopressor therapy 2. To study the choice of vasoactive agent, the average dose and duration of the agent 3. To understand the preoperative factors in patients requiring vasopressor / inotrope infusions e.g.comorbid conditions 4. To study the intraoperative factors e.g.type and duration of surgery, intraoperative fluid management strategy, blood loss, urine output, route of administration of vasopressorsetc 5. To study the postoperative factors such as need for and duration of postoperative fluid therapy, postoperative morbidity and mortality. Timepoint: Data will be collected 1. During surgery 2. At discharge from recovery room At discharge from hospital | — |
Countries
India
Contacts
Public ContactPrachi Rathod
Tata Memorial Centre, Mumbai
Outcome results
None listed